Search by Drug Name or NDC

    NDC 00409-1932-02 Adenosine 3 mg/mL Details

    Adenosine 3 mg/mL

    Adenosine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is ADENOSINE.

    Product Information

    NDC 00409-1932
    Product ID 0409-1932_af4ef593-85c4-472a-9d07-5cd821e25715
    Associated GPIs 94200005002010
    GCN Sequence Number 031430
    GCN Sequence Number Description adenosine VIAL 3 MG/ML INTRAVEN
    HIC3 A6V
    HIC3 Description CARDIOVASCULAR DIAGNOSTICS,NON-RADIOPAQUE AGENTS
    GCN 35352
    HICL Sequence Number 003734
    HICL Sequence Number Description ADENOSINE
    Brand/Generic Generic
    Proprietary Name Adenosine
    Proprietary Name Suffix n/a
    Non-Proprietary Name ADENOSINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 3
    Active Ingredient Units mg/mL
    Substance Name ADENOSINE
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203883
    Listing Certified Through 2024-12-31

    Package

    NDC 00409-1932-02 (00409193202)

    NDC Package Code 0409-1932-02
    Billing NDC 00409193202
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1932-02) / 30 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2014-04-02
    NDC Exclude Flag N
    Pricing Information N/A